Data di Pubblicazione:
2022
Abstract:
: Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by a homozygous GAA triplet repeat expansion in the frataxin gene. Cardiac involvement, usually manifesting as hypertrophic cardiomyopathy, can range from asymptomatic cases to severe cardiomyopathy with progressive deterioration of the left ventricular ejection fraction and chronic heart failure. The management of cardiac involvement is directed to prevent disease progression and cardiovascular complications. However, direct-disease therapies are not currently available for FRDA. The present review aims to describe the current state of knowledge regarding cardiovascular involvement of FRDA, focusing on clinical-instrumental features and management of cardiac manifestation.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Diagnosis; Friedreich ataxia; Hypertrophic cardiomyopathy; Left ventricular hypertrophy; Therapy
Elenco autori:
Monda, E.; Lioncino, M.; Rubino, M.; Passantino, S.; Verrillo, F.; Caiazza, M.; Cirillo, A.; Fusco, A.; Di Fraia, F.; Fimiani, F.; Amodio, F.; Borrelli, N.; Mauriello, A.; Natale, F.; Scarano, G.; Girolami, F.; Favilli, S.; Limongelli, G.
Link alla scheda completa:
Pubblicato in: